Strax

Autospela

Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL

2 Visningar • 07/14/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

In this episode, Mark Geyer and colleagues demonstrate that second-generation CD19-targeted CAR T cell therapy following conditioning chemotherapy is tolerated in patients with relapsed/refractory CLL and can result in complete remission in a subset of patients…

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela